BNP Paribas Asset Management
AMED

BNP Paribas Asset Management’s Amedisys AMED Stock Holding History

BNP Paribas Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-440
Closed -$43K – 1869
2025
Q2 		$43K Buy
+440
New +$41.6K ﹤0.01% 1192

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Asset Management's AMED Position: Q3 2025 in Review

BNP Paribas Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 440 shares — an estimated $43K sold.

BNP Paribas Asset Management first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $43K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • BNP Paribas Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Asset Management sold 440 Amedisys shares in Q3 2025, an estimated $43K.
  • BNP Paribas Asset Management first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • BNP Paribas Asset Management's Amedisys position peaked at $43K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on BNP Paribas Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.